Go to deals
Healthcare

CIT Safety & Health Research Lab has acquired the assets of LAB Research Inc.

CIT Safety & Health Research Laboratories (CIT) has acquired all the assets of LAB Research Inc.

CIT is part of the holding company Applied Biology Company (ABC). Through this acquisition, the newly created CIT-LAB group becomes one of the top five preclinical CROs. CIT is an established player in the field of preclinical contract research with more than forty years of experience.

LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petrochemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.

Oaklins' team in Canada advised the buyer in this transaction.

Parties

Talk to the deal team

Sebastien Nadeau

Managing Partner
Montreal, Canada
Oaklins E. Canada

Related deals

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Healthcare | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Learn more